Lactoferrin for prevention of neonatal sepsis

BioMetals

Volumn 27, Issue 5, 2014, Pages 1007-1016

  Turin, Christie G ^a   Zea Vera, Alonso ^a   Pezo, Alonso ^a   Cruz, Karen ^a   Zegarra, Jaime ^a,b   Bellomo, Sicilia ^a,b   Cam, Luis ^c   Llanos, Raul ^d   Castañeda, Anne ^d   Tucto, Lourdes ^a   Ochoa, Theresa J ^a,e  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

^b HOSPITAL NACIONAL CAYETANO HEREDIA   (Peru)

^c HOSPITAL NACIONAL ALBERTO SABOGAL SOLOGUREN   (Peru)

^d HOSPITAL NACIONAL GUILLERMO ALMENARA IRIGOYEN   (Peru)

^e UNIVERSITY OF TEXAS   (United States)

Author keywords

Bovine lactoferrin; Clinical trial; Lactoferrin; Neonatal sepsis; Prevention; Recombinant human lactoferrin

Indexed keywords

LACTOFERRIN; RECOMBINANT PROTEIN;

ANIMAL; BOVINE; FEMALE; HUMAN; LOW BIRTH WEIGHT; MALE; MICROBIOLOGY; NEWBORN; PREMATURITY; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEPSIS;

ANIMALS; CATTLE; FEMALE; HUMANS; INFANT, LOW BIRTH WEIGHT; INFANT, NEWBORN; INFANT, PREMATURE; LACTOFERRIN; MALE; RANDOMIZED CONTROLLED TRIALS AS TOPIC; RECOMBINANT PROTEINS; SEPSIS;

EID: 84920263812     PISSN: 09660844     EISSN: 15728773     Source Type: Journal    
DOI: 10.1007/s10534-014-9754-3     Document Type: Article

References (30)

1. Ammons MC, Copie V (2013) Mini-review: lactoferrin: a bioinspired, anti-biofilm therapeutic. Biofouling 29:443-455
2. Artym J, Zimecki M, Kruzel ML (2004) Enhanced clearance of Escherichia coli and Staphylococcus aureus in mice treated with cyclophosphamide and lactoferrin. Int Immunopharmacol 4:1149-1157
3. Baker HM, Baker EN (2012) A structural perspective on lactoferrin function. Biochem Cell Biol 90:320-328
4. Camacho-Gonzalez A, Spearman PW, Stoll BJ (2013) Neonatal infectious diseases: evaluation of neonatal sepsis. Pediatr Clin N Am 60:367-389
5. Edde L, Hipolito RB, Hwang FF, Headon DR, Shalwitz RA, Sherman MP (2001) Lactoferrin protects neonatal rats from gut-related systemic infection. Am J Physiol Gastrointest Liver Physiol 281:1140-1150
6. Embleton ND, Berrington JE, McGuire W, Stewart CJ, Cummings SP (2013) Lactoferrin: antimicrobial activity and therapeutic potential. Semin Fetal Neonatal 2013:143-149
7. Lee WJ, Farmer JL, Hilty M, Kim YB (1998) The protective effects of lactoferrin feeding against endotoxin lethal shock in germfree piglets. Infect Immun 66:1421-1426
8. Legrand D (2012) Lactoferrin, a key molecule in immune and inflammatory processes. Biochem Cell Biol 90:252-268
9. Leitch EC, Willcox MD (1999) Elucidation of the antistaphylococcal action of lactoferrin and lysozyme. J Med Microbiol 48:867-871
10. Lingappan K, Arunachalam A, Pammi M (2013) Lactoferrin and the newborn: current perspectives. Expert Rev Anti Infect Ther 11:695-707
11. Liu L, Johnson HL, Cousens S, Perin J, Scott S, Lawn JE et al (2012) Global, regional, and national causes of child mortality: an updated systematic analysis for 2010 with time trends since 2000. Lancet 379:2151-2161
12. Manzoni P, Rinaldi M, Cattani S, Pugni L, Romeo MG, Messner H et al (2009) Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA J Am Med Assoc 302:1421-1428
13. Manzoni P, Stolfi I, Messner H, Cattani S, Laforgia N, Romeo MG et al (2012) Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics 129:116-123
14. Nibbering PH, Ravensbergen E, Welling MM, van Berkel LA, van Berkel PH, Pauwels EK et al (2001) Human lactoferrin and peptides derived from its N terminus are highly effective against infections with antibiotic-resistant bacteria. Infect Immun 69:1469-1476
15. Ochoa TJ, Cleary TG (2009) Effect of lactoferrin on enteric pathogens. Biochimie 91:30-34
16. Ochoa TJ, Pezo A, Cruz K, Chea-Woo E, Cleary TG (2012) Clinical studies of lactoferrin in children. Biochem Cell Biol 90:457-467
17. Orsi N (2004) The antimicrobial activity of lactoferrin: current status and perspectives. Biometals 17:189-196
18. Shane AL, Stoll BJ (2013) Recent developments and current issues in the epidemiology, diagnosis, and management of bacterial and fungal neonatal sepsis. Am J Perinatol 30:131-142
19. Shane AL, Stoll BJ (2014) Neonatal sepsis: progress towards improved outcomes. J Infect 68:S24-S32
20. Sharma S, Kumar P, Betzel C, Singh TP (2001) Structure and function of proteins involved in milk allergies. J Chromatogr B Biomed Sci Appl 756:183-187
21. Sheffield CL, Crippen TL, Poole TL, Beier RC (2012) Destruction of single-species biofilms of Escherichia coli or Klebsiella pneumoniae subsp. pneumoniae by dextranase, lactoferrin, and lysozyme. Int Microbiol Off J Span Soc Microbiol 15:185-189
22. Singh PK, Parsek MR, Greenberg EP, Welsh MJ (2002) A component of innate immunity prevents bacterial biofilm development. Nature 417:552-555
23. Sun XL, Baker HM, Shewry SC, Jameson GB, Baker EN (1999) Structure of recombinant human lactoferrin expressed in Aspergillus awamori. Acta Crystallogr D Biol Crystallogr 55:403-407
24. Thaver D, Zaidi AK (2009) Burden of neonatal infections in developing countries: a review of evidence from community-based studies. Pediatr Infect Dis J 28:S3-S9
25. Venkatesh MP, Rong L (2008) Human recombinant lactoferrin acts synergistically with antimicrobials commonly used in neonatal practice against coagulase-negative Staphylococci and Candida albicans causing neonatal sepsis. J Med Microbiol 57:1113-1121
26. Vogel HJ (2012) Lactoferrin, a bird's eye view. Biochem Cell Biol 90:233-244
27. Watson D, O'Connell Motherway M, Schoterman MH, van Neerven RJ, Nauta A, van Sinderen D (2013) Selective carbohydrate utilization by lactobacilli and bifidobacteria. J Appl Microbiol 114:1132-1146
28. Zagulski T, Lipinski P, Zagulska A, Broniek S, Jarzabek Z (1989) Lactoferrin can protect mice against a lethal dose of Escherichia coli in experimental infection in vivo. Br J Exp Pathol 70:697-704
29. Zaidi AK, Huskins WC, Thaver D, Bhutta ZA, Abbas Z, Goldmann DA (2005) Hospital-acquired neonatal infections in developing countries. Lancet 365:1175-1188
30. Zhang GH, Mann DM, Tsai CM (1999) Neutralization of endotoxin in vitro and in vivo by a human lactoferrin-derived peptide. Infect Immun 67:1353-1358